Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Phase 1/2
82
about 5.7 years
18+
Male only
5 sites in FL, GA, NE +1
What this study is about
Researchers are testing a new treatment, Lutetium (177Lu) rhPSMA-10.1 injection, to see if it can help fight prostate cancer that has spread and become resistant to other treatments. The trial will involve men with advanced prostate cancer who have not responded well to hormone therapy. This is an interventional trial where participants receive the new treatment.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive 18F-rhPSMA-7.3 injection (in phase 1 only)
- 2.Receive Lutetium (177Lu) rhPSMA-10.1 Injection
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
injection
Primary: Phase 1 Frequency and nature of TEAEs
Oncology